BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 10688639)

  • 1. BSAP can repress enhancer activity by targeting PU.1 function.
    Maitra S; Atchison M
    Mol Cell Biol; 2000 Mar; 20(6):1911-22. PubMed ID: 10688639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Context-dependent Pax-5 repression of a PU.1/NF-kappaB regulated reporter gene in B lineage cells.
    Linderson Y; French NS; Neurath MF; Pettersson S
    Gene; 2001 Jan; 262(1-2):107-14. PubMed ID: 11179673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-terminal activating and inhibitory domains determine the transactivation potential of BSAP (Pax-5), Pax-2 and Pax-8.
    Dörfler P; Busslinger M
    EMBO J; 1996 Apr; 15(8):1971-82. PubMed ID: 8617244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The murine Ig 3' alpha enhancer is a target site with repressor function for the B cell lineage-specific transcription factor BSAP (NF-HB, S alpha-BP).
    Neurath MF; Strober W; Wakatsuki Y
    J Immunol; 1994 Jul; 153(2):730-42. PubMed ID: 8021508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corecruitment of the Grg4 repressor by PU.1 is critical for Pax5-mediated repression of B-cell-specific genes.
    Linderson Y; Eberhard D; Malin S; Johansson A; Busslinger M; Pettersson S
    EMBO Rep; 2004 Mar; 5(3):291-6. PubMed ID: 14993928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines.
    Arguello M; Sgarbanti M; Hernandez E; Mamane Y; Sharma S; Servant M; Lin R; Hiscott J
    Oncogene; 2003 Feb; 22(7):964-73. PubMed ID: 12592383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concerted repression of an immunoglobulin heavy-chain enhancer, 3' alpha E(hs1,2).
    Singh M; Birshtein BK
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4392-7. PubMed ID: 8633077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GATA-1 interacts with the myeloid PU.1 transcription factor and represses PU.1-dependent transcription.
    Nerlov C; Querfurth E; Kulessa H; Graf T
    Blood; 2000 Apr; 95(8):2543-51. PubMed ID: 10753833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A developmentally controlled competitive STAT5-PU.1 DNA binding mechanism regulates activity of the Ig κ E3' enhancer.
    Hodawadekar S; Park K; Farrar MA; Atchison ML
    J Immunol; 2012 Mar; 188(5):2276-84. PubMed ID: 22279106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein acetylation regulates both PU.1 transactivation and Ig kappa 3' enhancer activity.
    Bai Y; Srinivasan L; Perkins L; Atchison ML
    J Immunol; 2005 Oct; 175(8):5160-9. PubMed ID: 16210620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of BSAP/Pax-5 inhibits switching to IgA and enhances switching to IgE in the I.29 mu B cell line.
    Qiu G; Stavnezer J
    J Immunol; 1998 Sep; 161(6):2906-18. PubMed ID: 9743352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PU.1 can recruit BCL6 to DNA to repress gene expression in germinal center B cells.
    Wei F; Zaprazna K; Wang J; Atchison ML
    Mol Cell Biol; 2009 Sep; 29(17):4612-22. PubMed ID: 19564417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An interleukin-2 signal relieves BSAP (Pax5)-mediated repression of the immunoglobulin J chain gene.
    Rinkenberger JL; Wallin JJ; Johnson KW; Koshland ME
    Immunity; 1996 Oct; 5(4):377-86. PubMed ID: 8885870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments.
    Nutt SL; Morrison AM; Dörfler P; Rolink A; Busslinger M
    EMBO J; 1998 Apr; 17(8):2319-33. PubMed ID: 9545244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers.
    Brass AL; Zhu AQ; Singh H
    EMBO J; 1999 Feb; 18(4):977-91. PubMed ID: 10022840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-HB (BSAP) is a repressor of the murine immunoglobulin heavy-chain 3' alpha enhancer at early stages of B-cell differentiation.
    Singh M; Birshtein BK
    Mol Cell Biol; 1993 Jun; 13(6):3611-22. PubMed ID: 8497273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the PAX5/BSAP transcription factor in haematological tumour cells and further molecular characterization of the t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma.
    Hamada T; Yonetani N; Ueda C; Maesako Y; Akasaka H; Akasaka T; Ohno H; Kawakami K; Amakawa R; Okuma M
    Br J Haematol; 1998 Aug; 102(3):691-700. PubMed ID: 9722295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pax5 (BSAP) regulates the murine immunoglobulin 3' alpha enhancer by suppressing binding of NF-alpha P, a protein that controls heavy chain transcription.
    Neurath MF; Max EE; Strober W
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5336-40. PubMed ID: 7777508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the expression and function of the transcription factor PU.1 (Spi-1 proto-oncogene) between murine macrophages and B lymphocytes.
    Ross IL; Dunn TL; Yue X; Roy S; Barnett CJ; Hume DA
    Oncogene; 1994 Jan; 9(1):121-32. PubMed ID: 8302571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A two-step mechanism for recruitment of Pip by PU.1.
    Perkel JM; Atchison ML
    J Immunol; 1998 Jan; 160(1):241-52. PubMed ID: 9551977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.